100 related articles for article (PubMed ID: 6179584)
1. [Antigenicity of ovarian cancer tissues (author's transl)].
Gong Y
Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):156-8. PubMed ID: 6179584
[No Abstract] [Full Text] [Related]
2. [Studies on immunospecificity of skin test using tumor extract in gynecological malignancy (author's transl)].
Yuzawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):611-8. PubMed ID: 6165790
[TBL] [Abstract][Full Text] [Related]
3. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
4. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
Smith LH; Oi RH
Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
[TBL] [Abstract][Full Text] [Related]
5. Mib-1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance.
Marx D; Meden H; Brune T; Kron M; Korabiowska M; Kuhn W; Schauer A
Anticancer Res; 1997; 17(1B):775-80. PubMed ID: 9066619
[TBL] [Abstract][Full Text] [Related]
6. [The leukocyte adherence inhibition test in diagnostics of malignancies (author's transl)].
Sarosiek J; Borejszo I
Przegl Lek; 1981; 38(7):561-5. PubMed ID: 7025111
[No Abstract] [Full Text] [Related]
7. The leukocyte adherence inhibition test (LAI) in preoperative diagnosis of epithelial ovarian cancer.
Dgani R; Shani A; Elchalal U; Harpaz N; Bentwich Z; Fink A
Gynecol Oncol; 1993 Jun; 49(3):349-53. PubMed ID: 8314537
[TBL] [Abstract][Full Text] [Related]
8. [Assay of leucocyte adherence inhibition in patients with ovarian cancer].
Zhang SZ; Cai GR
Zhonghua Fu Chan Ke Za Zhi; 1986 Sep; 21(5):294-7, 319. PubMed ID: 3816401
[No Abstract] [Full Text] [Related]
9. [Possibility to use the LAI test (leucocyte adherence inhibition) for immunological examination of pregnant women with EPH gestosis (author's transl)].
Soukup K; Jandová A; Kobilková J; Trnka V; Vinsová N; Mejsnarová B; Samitrák J; Coupek J; Heyberger K
Cesk Gynekol; 1981 Aug; 46(7):524-6. PubMed ID: 7026060
[No Abstract] [Full Text] [Related]
10. The quest for a clearer understanding of ovarian carcinoma.
Beecham JB; Knauf SS
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1099-101. PubMed ID: 7028697
[No Abstract] [Full Text] [Related]
11. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
Schmeisser G; Kademann J
Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
[TBL] [Abstract][Full Text] [Related]
12. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
Tosner J; Fixa B
Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
[No Abstract] [Full Text] [Related]
13. [Immunobiological examination of women with spontaneous abortions (author's transl)].
Mejsnarová B; Jandová A; Novotná J; Motycka K; Heyberger K; Sanitrák J; Coupek J
Sb Lek; 1979; 81(11-12):337-40. PubMed ID: 390684
[No Abstract] [Full Text] [Related]
14. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
Varga A; Stosiek P; Kasper M
Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
[TBL] [Abstract][Full Text] [Related]
15. [Reverse hemagglutination (RHA) test for detection of ovarian cancer antigen in serum].
Liu WS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):308-9. PubMed ID: 2976323
[No Abstract] [Full Text] [Related]
16. Initial immunochemical characterization of MX35 ovarian cancer antigen.
Welshinger M; Yin BW; Lloyd KO
Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
[TBL] [Abstract][Full Text] [Related]
17. Expression of organ-specific neoantigens by human cancer.
Thomson DM
Prog Clin Biol Res; 1983; 132E():193-202. PubMed ID: 6196786
[No Abstract] [Full Text] [Related]
18. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.
Provencher DM; Finstad CL; Saigo PE; Rubin SC; Hoskins WJ; Federici MG; Stockert E; Lloyd KO; Lewis JL
Gynecol Oncol; 1993 Jul; 50(1):78-83. PubMed ID: 8349167
[TBL] [Abstract][Full Text] [Related]
19. [Attempts of checking up on the effects of treatment of gynecological cancer by means of the LAI test (author's transl)].
Novotná J; Kobilková J; Laurová L; Jandová A; Vinglerová H; Coupek K; Skoda V; Motycka K
Sb Lek; 1981; 83(11-12):326-31. PubMed ID: 7034144
[No Abstract] [Full Text] [Related]
20. CA125 antigen levels in obstetric and gynecologic patients.
Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
